ICCR AIDS report & responses
Interfaith Center on Corporate Responsibility report "Benchmarking AIDS": Company responses
In August 2006, the Interfaith Center on Corporate Responsibility (ICCR) issued a report, "Benchmarking AIDS: Evaluating pharmaceutical company responses to the public health crisis in emerging markets". A PowerPoint summary of the report, which includes scores and "bottom line" assessment of each company, is available here. The Business & Human Rights Resource Centre invited the 15 benchmarked companies to respond to the report; the results to date are indicated below. Below the companies' responses are rejoinders by ICCR and Physicians for Social Justice (Nigeria) to the companies' responses, and a November 2006 follow-up report by ICCR.
Company responses / non-responses:
Abbott Laboratories statement [DOC]
Boehringer-Ingelheim response [DOC]
Bristol-Myers Squibb response [DOC]
Eli Lilly - declined to respond
Gilead Sciences - declined to respond
GlaxoSmithKline response [DOC]
Hoffman-La Roche - declined to respond
sanofi-aventis - declined to respond
Schering-Plough - declined to respond
Tibotec (part of Johnson & Johnson) response [DOC]
Wyeth - press release sent in response to ICCR report
Rejoinders:
ICCR statement regarding the company responses (6 Nov 2006) [DOC]
Physicians for Social Justice (Nigeria) rejoinder to the company responses [DOC]
- Novartis response to Physicians for Social Justice [DOC]
Nov 2006 ICCR update:
Benchmarking AIDS: 2006 Year End Update [PDF]
- includes recent steps taken by Abbott, Gilead, GlaxoSmithKline, Novartis, Roche & recommendations for next steps for each of these companies
Related stories and components
Schering-Plough did not respond to: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Schering-Plough - finds none has comprehensive approach.
- Related in-depth areas: ICCR AIDS report & responses
- This is a non response from the following companies: Schering-Plough
Response by Bristol-Myers Squibb: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Bristol-Myers Squibb - finds none has comprehensive approach.
- Related in-depth areas: ICCR AIDS report & responses
- This is a response from the following companies: Bristol-Myers Squibb
Response by Merck: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Merck - finds none has comprehensive approach.
- Related in-depth areas: ICCR AIDS report & responses
- This is a response from the following companies: Merck
Response by Wyeth (part of Pfizer): Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Wyeth - finds none has comprehensive approach.
- Related in-depth areas: ICCR AIDS report & responses
- This is a response from the following companies: Wyeth (part of Pfizer)
Company responses to Interfaith Center on Corporate Responsibility report "Benchmarking AIDS"
Author: Compiled by Business & Human Rights Resource Centre
In August 2006, the Interfaith Center on Corporate Responsibility issued a report, "Benchmarking AIDS: Evaluating pharmaceutical company responses to the public health crisis in emerging markets"...The Business & Human Rights Resource Centre...
- Related stories: Interfaith Center on Corporate Responsibility - new report on pharmaceutical firms' responses to AIDS
- Related in-depth areas: ICCR AIDS report & responses
- Related companies: Abbott Laboratories AstraZeneca Boehringer Ingelheim Bristol-Myers Squibb Eli Lilly Gilead Sciences GlaxoSmithKline Hoffmann-La Roche (part of Roche) Johnson & Johnson Merck Novartis Pfizer Roche Sanofi Schering-Plough Tibotec (part of Johnson & Johnson) Wyeth (part of Pfizer)
Response by AstraZeneca: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including AstraZeneca - finds none has comprehensive approach.
- Related in-depth areas: ICCR AIDS report & responses
- This is a response from the following companies: AstraZeneca
Response by Boehringer Ingelheim: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Boehringer-Ingelheim - finds none has comprehensive approach.
- Related in-depth areas: ICCR AIDS report & responses
- This is a response from the following companies: Boehringer Ingelheim
Eli Lilly did not respond to: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Eli Lilly - finds none has comprehensive approach.
- Related in-depth areas: ICCR AIDS report & responses
- This is a non response from the following companies: Eli Lilly
Response by Novartis: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Novartis - finds none has comprehensive approach.
- Related in-depth areas: ICCR AIDS report & responses
- This is a response from the following companies: Novartis
Response by Pfizer: Interfaith Center on Corporate Responsibility rates 15 pharmaceutical firms on HIV/AIDS, including Pfizer - finds none has comprehensive approach.
- Related in-depth areas: ICCR AIDS report & responses
- This is a response from the following companies: Pfizer